technetium tc 99m sestamibi has been researched along with Lung Diseases, Obstructive in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ballinger, JR; Banney, L; Cheow, HK; Chilvers, ER; Evans, JW; Hartman, NG; Peters, AM; Ruparelia, P; Shankar, S; Swift, AE; Szczepura, KR | 1 |
| Furukawa, K; Kohno, S; Matsushita, T; Miyahara, Y; Nishijima, K | 1 |
2 other study(ies) available for technetium tc 99m sestamibi and Lung Diseases, Obstructive
| Article | Year |
|---|---|
Pulmonary elimination rate of inhaled 99mTc-sestamibi radioaerosol is delayed in healthy cigarette smokers.
Topics: Administration, Inhalation; Adult; Aged; ATP Binding Cassette Transporter, Subfamily B, Member 1; Female; Humans; Lung; Lung Diseases, Obstructive; Male; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Respiratory Function Tests; Smoking; Technetium Tc 99m Sestamibi | 2008 |
Simultaneous assessment of right ventricular function and hypertrophy by Tc-99m MIBI.
Topics: Female; Humans; Hypertrophy, Right Ventricular; Lung Diseases, Obstructive; Male; Middle Aged; Pulmonary Circulation; Pulmonary Veno-Occlusive Disease; Radiopharmaceuticals; Stroke Volume; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon; Ventricular Function, Right | 1999 |